Related Experiment Video
Updated: Apr 1, 2026
Neonatal Murine Cochlear Explant Technique as an In Vitro Screening Tool in Hearing Research
Published on: June 8, 2017
Cost-benefit analysis of targeted hearing directed early testing for congenital cytomegalovirus infection
Anna Bergevin1, Cathleen D Zick2, Stephanie Browning McVicar3
1Center for Public Policy & Administration, University of Utah, Salt Lake City, UT, United States.
Objectives:
In this study, we estimate an ex ante cost-benefit analysis of a Utah law directed at improving early cytomegalovirus (CMV) detection.
Study Design:
We use a differential cost of treatment analysis for publicly insured CMV-infected infants detected by a statewide hearing-directed CMV screening program.
Methods:
Utah government administrative data and multi-hospital accounting data are used to estimate and compare costs and benefits for the Utah infant population.
Results:
If antiviral treatment succeeds in mitigating hearing loss for one infant per year, the public savings will offset the public costs incurred by screening and treatment. If antiviral treatment is not successful, the program represents a net cost, but may still have non-monetary benefits such as accelerated achievement of diagnostic milestones.
Conclusions:
The CMV education and treatment program costs are modest and show potential for significant cost savings.
More Related Videos
05:53Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
Published on: July 6, 2013
14:05Behavioral Assessment of Hearing in 2 to 4 Year-old Children: A Two-interval, Observer-based Procedure Using Conditioned Play-based Responses
Published on: January 23, 2017
